# Neogenomics Inc: Form 8-K, filed Jan 15, 2025

- Company: [Neogenomics Inc](/companies/neo.md) (CIK 1077183)
- Form: 8-K
- Filed: 2025-01-15
- Accepted by EDGAR: Jan 15, 2025, 12:26 ET
- Period: 2025-01-14
- Accession: 0001077183-25-000007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000007/neo-20250114.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000007/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1077183/000107718325000007/neo-20250114.htm

Filed Jan 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001077183-25-000007. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.